Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Greenworks
301260
5
Tuoxin Pharmaceutical Group
301089
CN Stock MarketDetailed Quotes
300942 Shenzhen Bioeasy Biotechnology
- 9.30
- +0.19+2.09%
Market Closed May 16 15:00 CST
3.73BMarket Cap178.85P/E (TTM)
9.38High9.12Low71.57KlotVolume9.20Open9.11Pre Close66.12MTurnover1.78%Turnover Ratio216.28P/E (Static)401.32MShares11.4252wk High4.68P/B3.73BFloat Cap5.6752wk Low10.93Limit Up401.32MShs Float52.48Historical High7.29Limit Down2.85%Amplitude5.25Historical Low--Dividend TTM9.24Avg Price32.12KlotAsk--Div YieldTTM100Lot Size36.13KlotBid
Shenzhen Bioeasy Biotechnology Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 35.28%49.34M | -11.75%224.25M | -4.27%158.05M | -7.55%103.65M | -39.92%36.48M | -63.01%254.11M | -71.14%165.1M | -76.38%112.11M | -79.35%60.71M | 14.95%686.9M |
| Operating revenue | 35.28%49.34M | -11.75%224.25M | -4.27%158.05M | -7.55%103.65M | -39.92%36.48M | -63.01%254.11M | -71.14%165.1M | -76.38%112.11M | -79.35%60.71M | 14.95%686.9M |
| Other operating revenue | ---- | -76.95%2.43M | ---- | -68.55%1.16M | ---- | -0.43%10.54M | ---- | -26.26%3.7M | ---- | -26.51%10.58M |
| Interest income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Commission income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Premiums earned | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Total operating cost | 25.16%55.56M | -36.75%210.28M | -35.06%158.87M | -44.52%102.62M | -52.94%44.39M | -40.15%332.44M | -40.38%244.64M | -37.47%184.96M | -39.23%94.33M | 58.64%555.47M |
| Operating cost | 153.85%23.5M | -48.23%65.87M | -36.69%53.59M | -52.22%32.51M | -79.66%9.26M | -57.41%127.23M | -61.50%84.64M | -59.54%68.03M | -52.78%45.52M | 76.25%298.76M |
| Operating tax surcharges | 268.68%373.26K | -76.16%876.43K | -84.25%520.49K | -66.68%282.15K | -78.91%101.24K | 41.57%3.68M | 50.49%3.31M | -59.29%846.89K | -59.70%480.01K | -17.82%2.6M |
| Operating expense | 19.13%11.59M | -20.77%44.97M | -36.97%33.41M | -41.01%23.22M | -41.45%9.73M | -3.65%56.75M | -2.95%53.01M | 3.65%39.36M | -10.25%16.62M | 22.51%58.9M |
| Administration expense | -18.49%10.41M | -46.78%50.26M | -41.09%36.25M | -44.34%24.77M | -8.65%12.77M | 2.33%94.43M | -28.73%61.54M | -19.61%44.51M | -40.22%13.98M | 77.59%92.29M |
| Financial expense | -35.78%1.44M | 381.31%7.86M | 197.29%6.29M | 120.76%1.72M | 434.43%2.25M | 67.12%-2.79M | 51.19%-6.47M | 1.90%-8.28M | -715.84%-671.49K | -270.21%-8.5M |
| -Interest expense (Financial expense) | 18.96%6.42M | 75.63%18.67M | 168.52%12.08M | 133.97%8.28M | 357.16%5.39M | 160.28%10.63M | 168.48%4.5M | 270.30%3.54M | 137.71%1.18M | 71.65%4.08M |
| -Interest Income (Financial expense) | -38.38%-3.9M | -10.21%-8.33M | -13.14%-6.8M | -41.42%-5.6M | -25.56%-2.82M | -112.01%-7.56M | -117.47%-6.01M | -76.25%-3.96M | -726.20%-2.24M | -66.51%-3.56M |
| Research and development | -19.86%8.24M | -23.88%40.45M | -40.74%28.8M | -50.33%20.12M | -44.10%10.28M | -52.30%53.14M | -19.71%48.61M | -0.53%40.51M | 17.85%18.39M | 53.82%111.42M |
| Credit Impairment Loss | 149.90%1.37M | -128.46%-8.04M | -117.13%-5.49M | -950.98%-3.77M | -66.06%546.96K | 8.90%-3.52M | -543.40%-2.53M | 81.00%-358.71K | 126.51%1.61M | -32.32%-3.86M |
| Asset Impairment Loss | ---- | 96.20%-2.14M | 98.92%-183.84K | ---- | ---- | -16.78%-56.45M | -1,066.61%-17.03M | -1,211.12%-12.65M | ---- | -3,294.77%-48.34M |
| Other net revenue | 107.70%1.19M | 107.22%7M | 137.87%5.89M | 80.14%-2.17M | 585.21%573.01K | -191.01%-96.96M | -208.98%-15.55M | -290.97%-10.94M | -83.27%83.62K | -259.60%-33.32M |
| Fair value change income | 912.75%903.78K | 6,573.30%1.87M | 1,368.51%2.23M | 133.49%355.06K | -10.54%89.24K | --28.04K | 104.14%152.07K | 104.15%152.07K | -94.75%99.75K | ---- |
| Invest income | -25.61%-2.09M | 89.19%-5.85M | 23.97%-6.04M | 40.79%-3.04M | 55.26%-1.66M | -2,121.97%-54.11M | -202.81%-7.95M | -174.70%-5.13M | -447.26%-3.72M | -39.95%2.68M |
| -Including: Investment income associates | -17.09%-2.53M | 81.18%-10.33M | 5.86%-8.02M | 22.72%-4.25M | 41.93%-2.16M | -1,323.07%-54.87M | -714.82%-8.52M | -781.61%-5.49M | -1,214.10%-3.72M | -108.26%-3.86M |
| Asset deal income | -23.84%135.28K | -18.74%2.28M | 3.24%2.67M | -49.06%1.09M | 765.43%177.63K | 96.43%2.81M | 970.71%2.59M | 1,849.21%2.13M | --20.53K | --1.43M |
| Other revenue | -38.58%873.86K | 32.22%18.88M | 37.72%12.7M | -34.95%3.19M | -31.28%1.42M | -3.36%14.28M | -21.98%9.22M | -6.73%4.91M | -42.60%2.07M | -5.03%14.77M |
| Operating profit | 31.52%-5.03M | 111.96%20.96M | 105.33%5.07M | 98.63%-1.14M | 78.10%-7.34M | -278.68%-175.3M | -154.02%-95.09M | -145.40%-83.79M | -124.08%-33.53M | -63.43%98.11M |
| Add:Non operating Income | -28.94%8.99K | -63.43%356.65K | -82.72%150.69K | -98.08%14.58K | -86.43%12.65K | 471.57%975.15K | 1,876.42%872.08K | 1,617.10%757.66K | 233.44%93.24K | 52.89%170.61K |
| Less:Non operating expense | --15.44K | -52.98%1.63M | -75.35%498.99K | -88.70%108.48K | ---- | 2.36%3.47M | 46,627.53%2.02M | 93,593.78%959.74K | 1,397.11%2.41K | 871.49%3.39M |
| Total profit | 31.31%-5.03M | 111.07%19.69M | 104.90%4.72M | 98.53%-1.24M | 78.08%-7.33M | -287.38%-177.8M | -154.66%-96.24M | -145.50%-84M | -124.01%-33.44M | -64.60%94.89M |
| Less:Income tax cost | -1,331.16%-800.9K | -57.28%3.07M | -41.84%1.73M | 104.99%714.9K | 98.96%-55.96K | -41.21%7.19M | -89.28%2.98M | -143.05%-14.32M | -121.25%-5.36M | -61.28%12.22M |
| Net profit | 41.79%-4.23M | 108.98%16.62M | 103.01%2.99M | 97.20%-1.95M | 74.10%-7.27M | -323.78%-184.98M | -166.91%-99.22M | -146.03%-69.68M | -124.62%-28.09M | -65.04%82.66M |
| Net profit from continuing operation | 41.79%-4.23M | 108.98%16.62M | 103.01%2.99M | 97.20%-1.95M | 74.10%-7.27M | -323.78%-184.98M | -166.91%-99.22M | -146.03%-69.68M | -124.62%-28.09M | -65.04%82.66M |
| Less:Minority Profit | -445.68%-887.74K | -557.69%-497.12K | -1,466.96%-909.74K | -802.19%-393.33K | -570.04%-162.68K | 74.95%-75.59K | 20.27%-58.06K | 19.56%-43.6K | 20.85%-24.28K | -706.93%-301.7K |
| Net profit of parent company owners | 52.95%-3.35M | 109.26%17.12M | 103.93%3.9M | 97.76%-1.56M | 74.66%-7.11M | -322.87%-184.91M | -166.83%-99.16M | -145.99%-69.63M | -124.59%-28.06M | -64.92%82.97M |
| Earning per share | ||||||||||
| Basic earning per share | 53.11%-0.0083 | 108.70%0.04 | 103.92%0.0097 | 97.79%-0.0039 | 74.71%-0.0177 | -319.05%-0.46 | -166.85%-0.2474 | -146.45%-0.1765 | -125.00%-0.07 | -65.00%0.21 |
| Diluted earning per share | 53.11%-0.0083 | 108.70%0.04 | 103.92%0.0097 | 97.79%-0.0039 | 74.71%-0.0177 | -319.05%-0.46 | -166.85%-0.2474 | -146.45%-0.1765 | -125.00%-0.07 | -65.00%0.21 |
| Other composite income | -216.68%-209.89K | -142.88%-171.73K | -103.60%-64.86K | -100.06%-1.47K | -253.72%-66.28K | 111.26%400.47K | 42.27%1.8M | 1,485.06%2.62M | 153.62%43.11K | 121.18%189.56K |
| Other composite income of parent company owners | -216.68%-209.89K | -142.88%-171.73K | -103.60%-64.86K | -100.06%-1.47K | -253.72%-66.28K | 111.26%400.47K | 42.27%1.8M | 1,485.06%2.62M | 153.62%43.11K | 121.18%189.56K |
| Total composite income | 39.46%-4.44M | 108.91%16.45M | 103.00%2.92M | 97.09%-1.95M | 73.83%-7.34M | -322.78%-184.58M | -165.13%-97.41M | -144.25%-67.05M | -124.59%-28.04M | -64.83%82.85M |
| Total composite income of parent company owners | 50.46%-3.56M | 109.18%16.94M | 103.94%3.83M | 97.67%-1.56M | 74.38%-7.18M | -321.88%-184.51M | -165.06%-97.36M | -144.21%-67.01M | -124.57%-28.02M | -64.71%83.16M |
| Total composite income of minority owners | -445.68%-887.74K | -557.69%-497.12K | -1,466.96%-909.74K | -802.19%-393.33K | -570.04%-162.68K | 74.95%-75.59K | 20.27%-58.06K | 19.56%-43.6K | 20.85%-24.28K | -706.93%-301.7K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
Warren Buffett's Q1 Holdings Revealed: Has the Investment Trend Changed Drastically?
$Berkshire Hathaway-A (BRK.A.US)$ The first quarter Hold Positions report has been released, and the latest investment actions of the 'stock
Moomoo News Global
May 4 18:27
10 Unmissable Highlights of Berkshire's Shareholders Meeting